Ad Code

Responsive Advertisement

Ticker

    Loading......

Study finds less expensive noninvasive test is an effective alternative for colorectal cancer screening

Commercially available noninvasive screening tests for colorectal cancer—a fecal immunochemical test (FIT) and the multi-target stool DNAtest (mt-sDNA; or Cologuard®)—are equally effective for screening patients with early-stage colorectal cancer. However, a FIT costs about one-fifth of the multi-target DNA test, according to new study results presented at the Scientific Forum of the American College of Surgeons (ACS) Clinical Congress 2022.

from Medical Xpress - latest medical and health news stories https://ift.tt/T25ySHz